Liu W Q, Li Y Q, Jin L R, Jin P F, Zhu F C, Li J X
School of Public Health, Nanjing Medical University, Nanjing 211166, China.
School of Public Health, Southeast University, Nanjing 210009, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2025 Apr 10;46(4):724-729. doi: 10.3760/cma.j.cn112338-20240812-00492.
The master protocol design encompasses a comprehensive clinical trial protocol containing multiple sub-protocols, which can be used to evaluate the clinical intervention effects of various drugs or vaccines on various diseases. Particularly, this design strategy represents an efficient and innovative approach to trial design in the context of precision medicine. The master protocol design can be used for emerging infectious diseases and urgent vaccine development in complex situations. This review aims to outline the types and concepts of master protocol design, analyze the key points and details, and discuss its application scenarios in vaccine clinical evaluations. Additionally, it will explore potential challenges that may arise during implementation to provide references for optimizing emergency clinical trial designs of infectious disease vaccines in China.
主方案设计包含一个全面的临床试验方案,该方案包含多个子方案,可用于评估各种药物或疫苗对各种疾病的临床干预效果。特别是,这种设计策略代表了精准医学背景下一种高效且创新的试验设计方法。主方案设计可用于复杂情况下的新发传染病和紧急疫苗研发。本综述旨在概述主方案设计的类型和概念,分析要点和细节,并讨论其在疫苗临床评估中的应用场景。此外,还将探讨实施过程中可能出现的潜在挑战,为优化我国传染病疫苗应急临床试验设计提供参考。